Experimental Characterization of Spurious Signals in Magnetic Nanoparticles Enhanced Microwave Imaging of Cancer.

Magnetic nanoparticles enhanced microwave imaging relies on the capability of modulating the response of such nanocomponents at microwaves by means of a (low frequency) polarizing magnetic field. In medical imaging, this capability allows for the detection and imaging of tumors loaded with nanoparticles. As the useful signal is the one which arises from nanoparticles, it is crucial to remove sources of undesired disturbance to enable the diagnosis of early-stage tumors. In particular, spurious signals arise from instrumental drift, as well as from the unavoidable interaction between the polarizing field and the imaging system. In this paper, we experimentally assess and characterize such spurious effects in order to set the optimal working conditions for magnetic nanoparticles enhanced microwave imaging of cancer. To this end, simple test devices, which include all components typically comprised in a microwave imaging system, have been realized and exploited. The experiment's results allow us to derive design formulas and guidelines useful for limiting the impact of unwanted magnetic effects, as well as that relative to the instrumental drift on the signal generated by the magnetic nanoparticles-loaded tumor.

Optimization of the Working Conditions for Magnetic Nanoparticle-Enhanced Microwave Diagnostics of Breast Cancer.

Magnetic nanoparticle-aided microwave imaging is recently gaining an increasing interest as a potential tool for breast cancer diagnostics. This is due to the peculiar features of magnetic nanoparticles, which are biocompatible, can be selectively targeted to the tumor, and may change their microwave magnetic response when modulated by a polarizing magnetic field. This latter aspect is particularly appealing, as it enables the physical separation of the microwave signal due the malignancy, targeted by the nanoparticles, from that due to healthy tissue. This increases the specificity of the diagnostic tool, in principle allowing a diagnosis based solely on the detection of the signal due to the nanoparticles response. In this respect, a proper choice of the polarizing field modulation can remarkably increase the detection performances. This paper deals with this issue, by providing the mathematical framework for such an optimization and a procedure for estimating the required quantities from a set of proper measurements. The procedure is then experimentally demonstrated by applying it to a recently developed ultrawideband radar system for the magnetic nanoparticle-aided detection of breast cancer. For such a system, the optimal magnetic field modulation is determined.

Numerical assessment of a criterion for the optimal choice of the operative conditions in magnetic nanoparticle hyperthermia on a realistic model of the human head.

PURPOSE: This paper presents a numerical study aiming at assessing the effectiveness of a recently proposed optimisation criterion for determining the optimal operative conditions in magnetic nanoparticle hyperthermia applied to the clinically relevant case of brain tumours. MATERIALS AND METHODS: The study is carried out using the Zubal numerical phantom, and performing electromagnetic-thermal co-simulations. The Pennes model is used for thermal balance; the dissipation models for the magnetic nanoparticles are those available in the literature. The results concerning the optimal therapeutic concentration of nanoparticles, obtained through the analysis, are validated using experimental data on the specific absorption rate of iron oxide nanoparticles, available in the literature. RESULTS: The numerical estimates obtained by applying the criterion to the treatment of brain tumours shows that the acceptable values for the product between the magnetic field amplitude and frequency may be two to four times larger than the safety threshold of 4.85 × 10(8)A/m/s usually considered. This would allow the reduction of the dosage of nanoparticles required for an effective treatment. In particular, depending on the tumour depth, concentrations of nanoparticles smaller than 10 mg/mL of tumour may be sufficient for heating tumours smaller than 10 mm above 42 °C. Moreover, the study of the clinical scalability shows that, whatever the tumour position, lesions larger than 15 mm may be successfully treated with concentrations lower than 10 mg/mL. The criterion also allows the prediction of the temperature rise in healthy tissue, thus assuring safe treatment. CONCLUSIONS: The criterion can represent a helpful tool for planning and optimising an effective hyperthermia treatment.

Blind focusing of electromagnetic fields in hyperthermia exploiting target contrast variations.

This paper suggests a novel approach to the blind focusing of the electromagnetic field for microwave hyperthermia. The idea is to induce a contrast variation in the target and to exploit this variation for the synthesis of the excitations of the antenna array employed for the focusing, by performing a differential scattering measurement. In particular, the excitation vector is set as the right singular vector associated with the largest singular value of the differential scattering matrix, obtained as difference of two scattering matrixes measured by the antenna array itself before and after the contrast change. As a result, the approach is computationally effective and totally blind, not requiring any a priori knowledge of the electric and geometric features of the region hosting the target, as well as of its spatial position with respect to the antenna array.

Microwave cancer imaging exploiting magnetic nanoparticles as contrast agent.

In this paper, a microwave technique for breast cancer imaging is presented. The approach is based on the use of magnetic nanoparticles as contrast agent to induce a nonnull magnetic contrast selectively localized within the tumor. This allows us to face cancer imaging as the reconstruction of a magnetic contrast from the corresponding scattered field. To extract, from the measured data the contribution due to the magnetic contrast, i.e., the signal meaningful for cancer imaging, the approach exploits the possibility of modulating the magnetic response of magnetic nanoparticles by means of a polarizing magnetic field. The achievable reconstruction capabilities and the robustness against uncertainties on the electric features of the surrounding electric scenario are assessed by means of numerical examples.

On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia.

PURPOSE: Two points are particularly relevant for the clinical use of magnetic nanoparticle hyperthermia: the optimisation of both the exposure conditions and the magnetic nanoparticle characteristics, and the assessment of the limits of scalability of the treatment. To answer these two points a criterion for the individuation of the magnetic field parameters and of the magnetic nanoparticle features that minimise the therapeutic concentration of nanoparticles to be used in magnetic nanoparticle hyperthermia is developed. METHODS: The proposed criterion is based on the estimation of the levels of heat generation rate, due to the electromagnetic field, to be supplied to both the cancerous and the neighbouring healthy tissues for achieving the therapeutic heating of the tumour with a desired degree of spatial selectivity. These quantities are determined by exploiting the Pennes bioheat transfer model. RESULTS: The reliability of the criterion has been proven by means of an extensive numerical analysis, performed by considering tumours of spherical shape embedded in tissues of cylindrical shape. Several cases, including tumours of different sizes and position have been considered. CONCLUSIONS: By exploiting the proposed criterion a study of the clinical scalability of the therapeutic approach is presented.